Company Encyclopedia
View More
name
LIANHE TECHNOLOGY
002250.SZ
Lianhe Chemical Technology Co.,Ltd. engages in the production and sale of chemical products in China. It also offers crop protection products, including herbicides, pesticides, fungicides, plant growth regulators, and intermediates; and pharmaceuticals, fine chemicals, and functional chemicals, as well as engineering technology and equipment manufacturing services. Lianhe Chemical Technology Co.,Ltd.
1.888 T
002250.SZMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Specialty ChemicalsIndustry
Industry Ranking78/154
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE5.93%C
    • Profit Margin6.40%B
    • Gross Margin25.32%C
  • Growth ScoreB
    • Revenue YoY4.39%C
    • Net Profit YoY208.14%A
    • Total Assets YoY1.02%C
    • Net Assets YoY4.60%C
  • Cash ScoreB
    • Cash Flow Margin1561.97%B
    • OCF YoY4.39%C
  • Operating ScoreC
    • Turnover0.44C
  • Debt ScoreC
    • Gearing Ratio48.57%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Caitong Securities: The demand for phosphonamide monomers will flourish, and multinational pharmaceutical companies' supply chain enterprises are expected to benefit

    Caitong Securities released a research report indicating that phosphoramidite monomers play a key role in the development of small nucleic acid drugs, and demand is expected to grow significantly in the future. According to predictions from sphericalinsights, global sales of nucleotides will reach USD 730 million in 2023, with China being the largest production market, primarily focused on exports. Small nucleic acid drugs are considered potential treatment options for various diseases due to their unique molecular structure and therapeutic mechanisms, and companies within the supply chains of multinational pharmaceutical companies are expected to benefit from this

    Zhitong·
    SH
    688566
    +0.55%
    SH
    688136
    +0.21%
    SZ
    002250
    +0.92%
    Zhitong·
    SH
    688566
    +0.55%
    SH
    688136
    +0.21%
    SZ
    002250
    +0.92%

    LIANHE TECHNOLOGY released its performance for the first three quarters, with a net profit attributable to the parent company of 316 million yuan, a year-on-year increase of 871.65%

    According to the Zhitong Finance APP, LIANHE TECHNOLOGY released its third-quarter report for 2025. In the first three quarters, the company achieved operating revenue of 4.718 billion yuan, a year-on-year increase of 8.25%. The net profit attributable to shareholders of the listed company was 316 million yuan, a year-on-year increase of 871.65%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 300 million yuan, a year-on-year increase of 1504.44%

    Zhitong·
    SZ
    002250
    +0.92%
    Zhitong·
    SZ
    002250
    +0.92%

    LIANHE TECHNOLOGY: Has established cooperation with multiple leading companies in the new energy sector

    36Kr learned that LIANHE TECHNOLOGY stated on the interactive platform that the company has currently established cooperation and close connections with several leading new energy enterprises, including battery manufacturers and electrolyte manufacturers

    36Kr·
    SZ
    002250
    +0.92%
    36Kr·
    SZ
    002250
    +0.92%

    The "National Team" fund flow exposure Q2 increased stock list overview

    Choice data shows that the "national team" increased its holdings in 14 stocks in the second quarter, namely Dabeinong, RTGF, Zhenhua Heavy Industries, Tasly, LIANHE TECHNOLOGY, Zoomlion, Shaanxi Natural Gas, Tongbao Energy, Jingwei Hirain, CTC, HCNC, DS, Jiajiayue, and CITIC Special Steel

    Zhitong·
    SZ
    002440
    +0.26%
    SH
    600694
    +0.12%
    SZ
    300161
    +0.85%
    Zhitong·
    SZ
    002440
    +0.26%
    SH
    600694
    +0.12%
    SZ
    300161
    +0.85%

    LIANHE TECHNOLOGY: Net profit attributable to the parent company in the first half of the year increased by 1481.94% year-on-year

    On the evening of August 26, LIANHE TECHNOLOGY disclosed its semi-annual report, stating that the company achieved operating revenue of 3.15 billion yuan in the first half of the year, a year-on-year increase of 5.76%; the net profit attributable to shareholders of the listed company was 224 million yuan, a year-on-year increase of 1481.94%; basic earnings per share were 0.2457 yuan

    Zhitong·
    SZ
    002250
    +0.92%
    Zhitong·
    SZ
    002250
    +0.92%
    © 2025 Longbridge｜Disclaimer